PepsiCo, Inc. (NASDAQ:PEP) is making bold operational shifts across its global portfolio as it navigates shifting demand ...

Guidance was raised from $7.60–$7.90 EPS to $7.75–$8, now inclusive of tariffs. Margin expansion guidance increased from "upside to the midpoint" to a specified "150 to 200 basis points" for the year.

A trial testing a nerve-sparing (NeuroSAFE) technique in radical prostatectomy may improve patient-reported outcomes.

Breastfeeding did not appear to be associated with a higher risk of developing locoregional recurrences or contralateral breast cancers,” researchers wrote.

Background Restarting direct oral anticoagulants (DOACs) after a serious bleeding event in patients with atrial fibrillation ...

Q3 2025 Earnings Call Transcript July 14, 2025 Simulations Plus, Inc. beats earnings expectations. Reported EPS is $0.45, ...

The Motley Fool. DATE Tuesday, July 15, 2025 at 8:00 a.m. ET Read More: Earn up to $845 cash back this year just by changing ...

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.

Rivian is making significant progress towards profitability due to major cost reductions, despite current sales challenges in ...

A phase 3 trial of Cogent Biosciences’ bezuclastinib has hit its primary endpoint, teeing the biotech up to seek FDA approval ...

A Memphis police officer ran a red light, causing a car crash. The officer had an expired drivers license. Here's what else ...